His research focuses on pharmaceutical research and regulation. His work is often interdisciplinary and policy oriented. He is currently the Principal Investigator on a research grant entitled "Emerging health researchers and the commercialization of academic science" funded by the Canadian Institutes of Health Research, and he has appeared as an expert witness before several Canadian Parliamentary committees on the topic of pharmaceutical policy. Prior to arriving at Dalhousie, Matthew was the Ewing Marion Kauffman Foundation Legal Research Fellow at New York University School of Law, and he holds a Master of the Science of Law degree from Stanford Law School as well as LLM and LLB degrees from Dalhousie.